O Picard

1.7k total citations
48 papers, 1.1k citations indexed

About

O Picard is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, O Picard has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 19 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in O Picard's work include HIV Research and Treatment (20 papers), Cytomegalovirus and herpesvirus research (9 papers) and Immune Cell Function and Interaction (7 papers). O Picard is often cited by papers focused on HIV Research and Treatment (20 papers), Cytomegalovirus and herpesvirus research (9 papers) and Immune Cell Function and Interaction (7 papers). O Picard collaborates with scholars based in France, Belgium and United States. O Picard's co-authors include M F Poupon, Joël Gozlan, Marie‐Caroline Meyohas, Claudine Duvivier, Jean‐Claude Petit, J. Cabané, E Roullet, Adnane Achour, Magalie Baudrimont and L. Blum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Clinical Microbiology.

In The Last Decade

O Picard

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Picard France 20 490 303 250 185 182 48 1.1k
Corinne Amiel France 22 409 0.8× 619 2.0× 669 2.7× 121 0.7× 221 1.2× 68 1.6k
Motohiro Hamaguchi Japan 21 272 0.6× 189 0.6× 294 1.2× 59 0.3× 191 1.0× 69 1.7k
D E Lewis United States 20 425 0.9× 474 1.6× 409 1.6× 64 0.3× 509 2.8× 32 1.5k
Seymour Fein United States 17 207 0.4× 82 0.3× 78 0.3× 113 0.6× 233 1.3× 40 1.0k
A Coutellier France 15 1.1k 2.3× 269 0.9× 459 1.8× 934 5.0× 143 0.8× 33 1.7k
Hassen Kared France 19 263 0.5× 208 0.7× 260 1.0× 118 0.6× 954 5.2× 31 1.6k
Dirk Meyer‐Olson Germany 22 340 0.7× 573 1.9× 240 1.0× 177 1.0× 771 4.2× 55 1.4k
H.‐H. Brackmann Germany 24 418 0.9× 186 0.6× 239 1.0× 501 2.7× 124 0.7× 65 2.1k
Johnson T. Wong United States 23 453 0.9× 477 1.6× 191 0.8× 373 2.0× 673 3.7× 43 1.8k
F. Bouscarat France 14 339 0.7× 226 0.7× 183 0.7× 42 0.2× 193 1.1× 65 836

Countries citing papers authored by O Picard

Since Specialization
Citations

This map shows the geographic impact of O Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Picard more than expected).

Fields of papers citing papers by O Picard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Picard. The network helps show where O Picard may publish in the future.

Co-authorship network of co-authors of O Picard

This figure shows the co-authorship network connecting the top 25 collaborators of O Picard. A scholar is included among the top collaborators of O Picard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Picard. O Picard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picard, O & P. Cacoub. (2012). Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management. Clinics and Research in Hepatology and Gastroenterology. 36(5). 437–440. 13 indexed citations
2.
Bottero, Julie, Anders Boyd, Joël Gozlan, et al.. (2012). Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. Journal of Hepatology. 58(3). 473–478. 54 indexed citations
3.
Cacoub, P., Marc Bourlière, Jann Lübbe, et al.. (2011). Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals. Journal of Hepatology. 56(2). 455–463. 94 indexed citations
4.
Préau, Marie, Anne‐Déborah Bouhnik, Bruno Spire, et al.. (2006). Qualité de vie et syndrome lipodystrophique chez les patients infectés par le VIH. L Encéphale. 32(5). 713–719. 10 indexed citations
5.
Picard, O. (2002). Infections herpétiques et virus de l’immunodéficience humaine. Pathologie Biologie. 50(7). 460–462. 2 indexed citations
6.
Defer, Marie-Christine, Jean-Yves Follézou, Bernard Dugas, et al.. (2001). Differential Pattern in Circulating Nitrogen Derivatives, Lactoferrin, and Anti-Lactoferrin Antibodies in HIV Type 1 and HIV Type 2 Infections. AIDS Research and Human Retroviruses. 17(11). 1041–1045. 4 indexed citations
7.
Serfaty, Lawrence, Dominique Costagliola, Dominique Wendum, et al.. (2001). Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case–control study. AIDS. 15(15). 2011–2016. 31 indexed citations
8.
Picard, O, et al.. (1997). Cerebral infarction associated with vasculitis due to varicella zoster virus in patients infected with the human immunodeficiency virus. Biomedicine & Pharmacotherapy. 51(10). 449–454. 21 indexed citations
9.
Levy, David A., Pauline Roux, O Picard, et al.. (1995). Histoplasmose à Histoplasma capsulatum et sida. La Revue de Médecine Interne. 16(6). 407–412. 4 indexed citations
10.
Laudat, Antoine, L. Blum, Jérôme Guechot, et al.. (1995). Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts. European Journal of Endocrinology. 133(4). 418–424. 72 indexed citations
11.
Achour, Adnane, et al.. (1995). HIV-1 soluble antigens induced CD8+ cytotoxic T-cell responses in an immunized individual.. PubMed. 41(3). 395–400. 2 indexed citations
12.
Achour, Adnane, O Picard, Jean‐François Zagury, et al.. (1994). Cytotoxic T Lymphocytes Specific for HIV-1 gp160 Antigen and Synthetic P18III B Peptide in an HLA-A11-Immunized Individual. AIDS Research and Human Retroviruses. 10(1). 19–25. 19 indexed citations
13.
Picard, O. (1994). Antiretroviral therapy for human immunodeficiency virus infection: hope and despair. Biomedicine & Pharmacotherapy. 48(2). 85–88.
14.
Achour, Ammar, O Picard, Andreas Willer, et al.. (1993). Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope. Vaccine. 11(7). 699–701. 21 indexed citations
15.
Gozlan, Joël, E Roullet, Magalie Baudrimont, et al.. (1992). Rapid Detection of Cytomegalovirus DNA in Cerebrospinal Fluid of AIDS Patients with Neurologic Disorders. The Journal of Infectious Diseases. 166(6). 1416–1421. 88 indexed citations
16.
Willer, Andreas, Adnane Achour, A Lachgar, et al.. (1992). Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomedicine & Pharmacotherapy. 46(8). 359–365. 6 indexed citations
17.
Carelli, C, A. Halbreich, Jacky Bernard, et al.. (1992). Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparations. Biomedicine & Pharmacotherapy. 46(4). 149–153. 8 indexed citations
18.
Picard, O, Jacky Bernard, A Lachgar, et al.. (1992). Removal of GP160 induced bio-hazards for a safe AIDS vaccine candidate. Biomedicine & Pharmacotherapy. 46(8). 353–357. 3 indexed citations
19.
Bernard, Jacky, Brigitte Réveil, O Picard, et al.. (1990). Discrimination Between Protective and Enhancing HIV Antibodies. AIDS Research and Human Retroviruses. 6(2). 243–249. 10 indexed citations
20.
Khalife, Jamal, Lionel Prin, J Lebas, et al.. (1989). Syndrome hyperéosinophilique chez un sujet HIV I +. La Revue de Médecine Interne. 10(3). 249–252. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinne Amiel Breakdown of academic impact, for papers by Motohiro Hamaguchi Breakdown of academic impact, for papers by D E Lewis Breakdown of academic impact, for papers by Seymour Fein Breakdown of academic impact, for papers by A Coutellier Breakdown of academic impact, for papers by Hassen Kared Breakdown of academic impact, for papers by Dirk Meyer‐Olson Breakdown of academic impact, for papers by H.‐H. Brackmann Breakdown of academic impact, for papers by Johnson T. Wong Breakdown of academic impact, for papers by F. Bouscarat
Rankless by CCL
2026